BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9630374)

  • 1. The epidemiology and typing of Clostridium difficile.
    Brazier JS
    J Antimicrob Chemother; 1998 May; 41 Suppl C():47-57. PubMed ID: 9630374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Typing of Clostridium difficile.
    Brazier JS
    Clin Microbiol Infect; 2001 Aug; 7(8):428-31. PubMed ID: 11591206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiology of Clostridium difficile infection].
    Szczesny A; Martirosian G
    Przegl Epidemiol; 2002; 56(1):49-56. PubMed ID: 12150067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confronting Clostridium difficile in inpatient health care facilities.
    McDonald LC
    Clin Infect Dis; 2007 Nov; 45(10):1274-6. PubMed ID: 17968820
    [No Abstract]   [Full Text] [Related]  

  • 5. Clostridium difficile ribotype 027 is not evenly distributed in Hesse, Germany.
    Arvand M; Bettge-Weller G
    Anaerobe; 2016 Aug; 40():1-4. PubMed ID: 27063988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nosocomial infection with Clostridium difficile investigated by pyrolysis mass spectrometry.
    Cartmill TD; Orr K; Freeman R; Sisson PR; Lightfoot NF
    J Med Microbiol; 1992 Nov; 37(5):352-6. PubMed ID: 1433258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experiences with outbreak of Clostridium difficile 027].
    Olesen B
    Ugeskr Laeger; 2010 Mar; 172(12):952. PubMed ID: 20334786
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of toxin A negative/B positive Clostridium difficile strains.
    Brazier JS; Stubbs SL; Duerden BI
    J Hosp Infect; 1999 Jul; 42(3):248-9. PubMed ID: 10440000
    [No Abstract]   [Full Text] [Related]  

  • 9. Outbreak of Clostridium difficile ribotype 027 in a residential home.
    Clayton JJ; McHale-Owen J
    J Hosp Infect; 2014 Dec; 88(4):222-5. PubMed ID: 25447200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile--setting the scene.
    Wilcox MH
    J Antimicrob Chemother; 1998 May; 41 Suppl C():1-3. PubMed ID: 9630368
    [No Abstract]   [Full Text] [Related]  

  • 11. Clostridium difficile: from obscurity to superbug.
    Brazier JS
    Br J Biomed Sci; 2008; 65(1):39-44. PubMed ID: 18476496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile: familiar pathogen, changing epidemiology: a virulent strain has been appearing more often, even in patients not taking antibiotics.
    Todd B
    Am J Nurs; 2006 May; 106(5):33-6. PubMed ID: 16639241
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004.
    Barbut F; Gariazzo B; Bonné L; Lalande V; Burghoffer B; Luiuz R; Petit JC
    Infect Control Hosp Epidemiol; 2007 Feb; 28(2):131-9. PubMed ID: 17265393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Has the severity of Clostridium difficile infections increased?
    Das I; Jumaa P
    J Hosp Infect; 2007 Jan; 65(1):85-6. PubMed ID: 17055114
    [No Abstract]   [Full Text] [Related]  

  • 15. Clostridium difficile infection following hip fracture.
    Fenton P; Singh K; Cooper M
    J Hosp Infect; 2008 Apr; 68(4):376-7. PubMed ID: 18353494
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiology and typing of Clostridium difficile.
    Jumaa P; Wren B; Tabaqchali S
    Eur J Gastroenterol Hepatol; 1996 Nov; 8(11):1035-40. PubMed ID: 8944362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An outbreak of Clostridium difficile-associated disease (CDAD) in a German university hospital.
    Graf K; Cohrs A; Gastmeier P; Kola A; Vonberg RP; Mattner F; Sohr D; Chaberny IF
    Eur J Clin Microbiol Infect Dis; 2009 May; 28(5):543-5. PubMed ID: 18982365
    [No Abstract]   [Full Text] [Related]  

  • 18. Surveillance for resistance to metronidazole and vancomycin in genotypically distinct and UK epidemic Clostridium difficile isolates in a large teaching hospital.
    Freeman J; Stott J; Baines SD; Fawley WN; Wilcox MH
    J Antimicrob Chemother; 2005 Nov; 56(5):988-9. PubMed ID: 16195254
    [No Abstract]   [Full Text] [Related]  

  • 19. Clostridium difficile ribotype 027, toxinotype III, the Netherlands.
    Kuijper EJ; van den Berg RJ; Debast S; Visser CE; Veenendaal D; Troelstra A; van der Kooi T; van den Hof S; Notermans DW
    Emerg Infect Dis; 2006 May; 12(5):827-30. PubMed ID: 16704846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clostridium difficile ribotype 027, toxinotype III in The Netherlands].
    Kuijper EJ; Debast SB; Van Kregten E; Vaessen N; Notermans DW; van den Broek PJ
    Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2087-9. PubMed ID: 16201596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.